Stephen Gellis, MD
Dermatologist, Dermatology Program
Assistant Professor of Dermatology (Pediatrics), Harvard Medical School
Image
Stephen Gellis, MD
Dermatologist, Dermatology Program
Assistant Professor of Dermatology (Pediatrics), Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
Tufts University
1969
Medford
MA
Medical School
Harvard Medical School
1974
Boston
MA
Internship
Boston Children's Hospital
1974
Boston
MA
Residency
Boston Children's Hospital
1976
Boston
MA
Residency
Dermatology
Massachusetts General Hospital
1978
Boston
MA
Certifications
American Board of Dermatology (General)
American Board of Dermatology (Pediatric Dermatology)
Professional History
Dr. Stephen Gellis is a master clinician in pediatric dermatology. He is trained in both pediatrics and dermatology. He served as Director of the Boston Children's Hospital Dermatology Program for 33 years and has trained and mentored countless pediatricians and dermatologists. Currently, he practices at the Main Campus in Boston and at our Lexington location.
Publications
Topical corticosteroids for noninvasive treatment of pyogenic granulomas. View Abstract
Pediatric facial pyoderma gangrenosum preceding the diagnosis of inflammatory bowel disease. View Abstract
Clinical features and outcomes of spitzoid proliferations in children and adolescents. View Abstract
Eosinophilic annular erythema treated with dupilumab. View Abstract
Herpes zoster at the vaccination site in immunized healthy children. View Abstract
Primary Cutaneous B-Cell Lymphoblastic Lymphoma Arising from a Long-Standing Lesion in a Child and Review of the Literature. View Abstract
Pediatric Pemphigus Herpetiformis: Case Report and Review of the Literature. View Abstract
Neurovascular Stains in Two Girls with Neurofibromatosis 1. View Abstract
Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome associated with neonatal epidermolysis bullosa acquisita. View Abstract
Rapidly fatal multiorgan Langerhans cell histiocytosis in a neonate. View Abstract
A case of recalcitrant epidermolysis bullosa acquisita responsive to rituximab therapy. View Abstract
Hand, foot, and mouth disease caused by coxsackievirus a6. View Abstract
Picture of the month-quiz case. Infantile Fibrosarcoma. View Abstract
Agminated atypical Spitz tumor: large nasal lesion in a child with Down syndrome. View Abstract
Fever, oral ulcerations, arthralgias, neutropenia, and a polycyclic skin eruption in a 14-year-old girl. View Abstract
Characteristics of mycobacterial infection in patients with immunodeficiency and nuclear factor-kappaB essential modulator mutation, with or without ectodermal dysplasia. View Abstract
Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. View Abstract
Psoriatic eruption in Kawasaki disease. View Abstract
Pioneers and modern ideas. General pediatrics. View Abstract
Epidermolytic hyperkeratosis. View Abstract
Lymphomatoid papulosis in children. View Abstract
Neonatal lupus erythematosus and maternal lupus erythematosus mimicking HELLP syndrome. View Abstract
Spirochetes in atrophic skin lesions accompanied by minimal host response in a child with Lyme disease. View Abstract
Bullous diseases of childhood. View Abstract
Amino acid metabolism in infectious hepatitis. View Abstract
CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXVI. INACTIVATION OF THE VIRUS OF HOMOLOGOUS SERUM HEPATITIS IN SOLUTIONS OF NORMAL HUMAN SERUM ALBUMIN BY MEANS OF HEAT. View Abstract
Chemical, clinical, and immunological studies on the products of human plasma fractionation; inactivation of the virus of homologous serum hepatitis in solutions of normal human serum albumin by means of heat. View Abstract
STUDIES ON THE RELATIONSHIP OF THE HEPATITIS VIRUS TO PERSISTENT SYMPTOMS, DISABILITY, AND HEPATIC DISTURBANCE ("CHRONIC HEPATITIS SYNDROME") FOLLOWING ACUTE INFECTIOUS HEPATITIS. View Abstract
CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XI. THE USE OF CONCENTRATED NORMAL HUMAN SERUM GAMMA GLOBULIN (HUMAN IMMUNE SERUM GLOBULIN) IN THE PROPHYLAXIS AND TREATMENT OF MEASLES. View Abstract